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Abstract. Microarray technology allows measuring the expression levels of 
thousands of genes providing huge quantities of data to be analyzed. This fact 
makes fundamental the use of computational methods as well as new intelligent 
algorithms. This paper presents a Case-based reasoning (CBR) system for 
automatic classification of microarray data. The CBR system incorporates novel 
algorithms for data classification and knowledge discovery. The system has 
been tested in a case study and the results obtained are presented. 
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1   Introduction 
The use of microarrays, and more specifically expression arrays, enables the analysis 
of different sequences of oligonucleotides [1], [2]. Simply put a microarray is an array 
of probes that contains genetic material with a predetermined sequence. These se-
quences are hybridized with the genetic material of patients, thus allowing the detec-
tion of genetic mutations through the analysis of the presence or absence of certain 
sequences of genetic material. This work focuses on the levels of expression for the 
different genes, as well as on the identification of the probes that characterize the 
genes and allow the classification into groups. 
The analysis of expression arrays is called expression analysis. An expression 
analysis basically consists of three stages: normalization and filtering; clustering and 
classification; and extraction of knowledge. These stages are carried out from the 
luminescence values found in the probes. Presently, the number of probes containing 
expression arrays has increased considerably to the extent that it has become neces-
sary to use new methods and techniques to analyze the information more efficiently. 
There are various artificial intelligence techniques such as artificial neural networks 
[4], [5], Bayesian networks [6], and fuzzy logic [7] which have been applied to mi-
croarray analysis. While these techniques can be applied at various stages of expres-
sion analysis, the knowledge obtained cannot be incorporated into successive tests 
and included in subsequent analyses.  
This paper presents a system based on CBR which uses past experiences to solve 
new problems [8], [9]. As such, it is perfectly suited for solving the problem at hand. 
In addition, CBR makes it possible to incorporate the various stages of expression 
analysis into the reasoning cycle of the CBR, thus facilitating the creation of  
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strategies similar to the processes followed in medical laboratories. The recovery of 
information from previous analyses simplifies the classification process by detecting 
and eliminating relevant and irrelevant probes detected in previous analyses. This sys-
tem is applied to the classification of subtypes of leukemia, specifically, to detect pat-
terns and extract subgroups within the CLL type of leukemia obtained from the HG 
U133 plus [3] expression arrays. The CBR system is based on previous works [10], 
[11] but the stages of the CBR cycle have been modified. The system incorporates new 
techniques for improving the filtering in the retrieval stage; The reuse phase now in-
cludes a parallel execution of the ESOINN (Enhanced Self-Organizing Incremental 
Neural Network) [12] neural network and the  PAM [13], which facilitates a better 
evaluation of the classification provided; the revise phase includes a MDS (Multidi-
mensional Scaling) technique [14] to obtain representations at low dimensionality. 
The paper is structured as follows: Section 2 presents and describes the novel 
strategies incorporated in the stages of the CBR cycle. Section 3 describes a case 
study specifically developed to evaluate the CBR system presented within this study. 
Section 4 presents the results and conclusions obtained after testing the model. 
2   Microarray Data Analyses  
This section presents the CBR system proposed in the context of this research and 
provides a classification technique based on previous experiences for data from mi-
croarrays. The system receives data from the analysis of chips and is responsible for 
classifying individuals based on evidence and existing data. The primary concept 
when working with CBRs is the concept of case. A case can be defined as a past ex-
perience, and is composed of three elements: a problem description which describes 
the initial problem; a solution which provides the sequence of actions carried out in 
order to solve the problem; and the final stage which describes the state achieved once 
the solution was applied. A CBR manages cases (past experiences) to solve new prob-
lems. The way cases are managed is known as the CBR cycle, and consists of four 
sequential steps which are recalled every time a problem needs to be solved: retrieve, 
reuse, revise and retain.  
The CBR system previously designed [10] has been modified and incorporate new 
techniques in each of the stages of the CBR cycle. A new rules memory was incorpo-
rated to the CBR to store the rules obtained during the revise stage. The retrieve 
phase, includes a new additional step. Once the most important variables have been 
retrieved, the reuse phase begins adapting the solutions for the retrieved cases to ob-
tain the clustering. The clustering is now obtained by means of two different tech-
niques, which results are compared. Once this grouping is accomplished, the next step 
is knowledge extraction. The revise phase consists of an expert revision for the pro-
posed solution. To facilitate this task, we have incorporated a MDS, and finally, the 
retain phase allows the system to learn from the experiences obtained in the three 
previous phases, consequently updating the cases memory and the new rules memory. 
2.1   Retrieve 
Traditionally, only the cases similar to the current problem are recovered, often be-
cause of performance, and then adapted. With regards to expression array, the number 
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of cases is not a critical factor, rather the number of variables. For this reason, we 
have incorporated an innovative strategy where variables are retrieved at this stage 
and then, depending on the identified variables, the rest of the stages of the CBR are 
carried out. In the previous version of the CBR, the retriever phase consisted of: 
RMA, remove irrelevant probes, low variability, uniform distribution and correla-
tions. A new step has been incorporated in the filtering to obtain a more effective 
reduction of the number of the significant probes. 
2.1.1   Cut-Off Points 
This step removes the probes that, despite not following a uniform distribution, have 
no separation between elements, and do not allow the elements to be partitioned. The 
way to remove the probes is to detect changes in the densities of the data, and to se-
lect the final probes. The probes in which cut-offs or high densities are not detected 
are eliminated, as they do not provide useful information to the classification process. 
This will keep the probes that allow the separation of individuals. The detection of the 
separation intervals is performed by calculating the distance between adjacent indi-
viduals. Once the distance is calculated, it is possible to determine the potentially 
relevant values. The selection is carried out by applying confidence intervals for the 
values of these differences if the values follow a uniform distribution, or by selecting 
the values above a certain percentile if the values do not follow a normal distribution. 
This process is formalized as follows: 
1. Let 'I  be the set of individuals with filtered probes together with the new in-
dividual, where jx⋅  represents the probe j for all the individuals, and ijx the 
individual i for the probe j  
2. Select the probe 1=j , jx⋅  
3. Sort in increasing order values jx⋅  
4. Calculate the value for ijjiij xxx −= +1'  
5. Determine if the variable ijx'  follows a uniform distribution by means of the 
Shapiro-Wilk test [19], otherwise go to step 10. 
6. Calculate the value for '. jx  
























 with 05.0=α and jxn ⋅= '# and the 
number of elements for jx ⋅' , S  is the sampling variance. 




∉= σ  
9. Go to step 11. 
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10. Select those values up to the percentile αP  from every jx ⋅' and establish the 
set { }αPxxQ ijijj >= '/'   
11. Select the probe j+1 in the case of more probes needing revision and go to step 2. 
12. Create the new set of probes 
uxxiuxiQxxI jijj ⋅−<∧⋅>∈∃= ⋅ '#'#'#/'/'' ∪  
13. Finalize and return the new set of individuals with the filtered probes 'I  
2.2   Reuse 
The reuse phase has been modified: The classification was performed by an ESOINN 
neural network. The new reuse stage incorporates a PAM technique. Both PAM and 
ESOINN are executed simultaneously, and their results are compared.  
2.2.1   PAM 
The PAM algorithm [13] is executed parallel to the clustering in order to facilitate a 
comparison of the results obtained. The classification made by both methods, PAM 
and ESOINN, generates an equivalence index between the two methods that deter-
mines the consistency of the reuse phase. The algorithm used for PAM is as follows: 
1. Select the number of clusters depending on C# , where C  is the set of  
different classes in 'I  
2. Classify the patients taking all of the variables into account, without any  
filtering }/{ IggG PPP ⊆=  with jigg Pj
P
i ≠∀=∩ ,φ  



















  (1) 
where }/{' jc csIsI j ∈∈= , I  is the set of initial individuals, jc  is the 
class j , and pic gI j /' is the set of individuals from jc restricted to 
p
ig . 
2.2.2   Equivalence Index 
Once the individuals have been classified using both the PAM and the ESOINN neu-
ral networks, the equivalence index for both methods eq  is calculated, and the error 
rate for the ESOINN network is determined as a function of the pre-classified cases. 










j ∈∧∈∈=  (2) 
Where Ejc , 
P
jc  representan las clases j bajo la red ESOINN y PAM. 
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2.2.3   Classification 
Once the meshes are generated by the clustering process, previously unclassified 
individuals are now classified by selecting the nearest mesh. When the mesh has been 
selected, the case is assigned to the class of the mesh selected.  
2.3   Revise 
To facilitate the human expert task, the equivalence index and the error rate were 
calculated in the reuse stage. It is important for the medical human expert to under-
stand the classification process performed in the two previous stages. In this sense, the 
system provides a knowledge extraction method in the Revise phase. This method 
analyses the steps followed in the retrieve and reuse stages, and extracts knowledge 
which is then formalized in rules. In this way, the human expert can easily evaluate 
the classification and extract conclusions concerning the efficiency of the classifica-
tion process. It has been incorporated knowledge about the probes that cause errone-
ous classifications. The knowledge extraction phase detects anomalous classifications, 
since it accounts for the existence of probes with irrelevant information, or those that 
were decisive for the misclassification. If the human expert notes that the probes con-
tain irrelevant information, they are marked as irrelevant and not taken into account in 
the next iteration of the CBR cycle. At this stage, in addition to the representation of 
the decision tree, a 3D representation with the information retrieved is displayed. The 
dimensionality is reduced by using MDS [14]. 
2.4   Retain 
If the human expert identifies relevant information at the revise stage, the knowledge 
is acquired and the information obtained is stored. The information that is stored cor-
responds to the classifications considered correct, the decision rules generated that are 
considered relevant, and the probes marked as irrelevant. The information stored is 
divided into the cases memory and the rules memory. 
3   Case Study 
Microarray analysis has facilitated the identification of certain characteristic genes in 
the different variants of leukemia [15]. Cancer experts remark on the importance of  
the identification of the genes associated to each type of cancer in order to establish 
the most efficient treatments for the patients [20].  
The Institute Cancer Institute of Salamanca provided us with 91 samples of patient 
data and asked for a tool to provide decision support in the expression array analysis 
process and to incorporate innovative techniques to reduce the dimensionality of the 
data and identify the variables with a higher influence in the patient’s classification. 
The samples corresponded to patients affected by chronic lymphocytic leukemia. CLL 
is a disease of lymphocytes that appear to be mature but are biologically immature. 
These B lymphocytes arise from a subset of CD5-B cells that appear to have a role in 
autoimmunity. The pathogenesis of chronic lymphocytic leukemia is likely a 
multistep process, initially involving a polyclonal expansion of CD5-B cells followed 
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by the transformation of a single cell [17]. CLL is one of four main types of leu-
kemia. About 15.110 new cases of CLL will be diagnosed in 2008. Approximately 
90.179 people are currently living with CLL, more than the number of people liv-
ing with any other type of leukemia.  Most people with CLL are at least 50 years 
old [18]. CLL starts with a change to a single cell called a lymphocyte. Over time, 
the CLL cells multiply and replace normal lymphocytes in the marrow and lymph 
nodes. The high number of CLL cells in the marrow may crowd out normal blood-
forming cells, and CLL cells are not able to fight off infection like normal lym-
phocytes do [18]. The aim of the tests performed in this study is to determine 
whether our system is able to classify new patients based on previously analyzed 
and stored cases.  
4   Results and Conclusions 
This paper has presented case-based reasoning system specifically designed to ana-
lyze data from microarrays, facilitating the grouping and classification of individuals. 
Moreover, the system provides an innovative method for exploring the classification 
process and extracting knowledge in the form of rules which help the human experts 
to understand the classification process and obtain conclusions about the relevance of 
the probes. The system has been applied to a real case scenario at the Cancer Institute 
in the city of Salamanca, for classifying CLL leukemia patients. The human experts in 
the laboratory have remarked on the advantages of using MicroCBR as a decision 
support system for CLL classification, and have especially noted the facility in  
acquiring knowledge and explanations.   
Section 3 presented the case study considered in this report, which classified 91 
CLL leukemia patients into groups. The aim of the case study was to identify the 
probes that allow classifying the CLL leukemia patients into subgroups. The pre-
processing phase began with 54.675 probes. After the pre-processing phase, the filter-
ing process was applied, notably reducing the probes to 618, without increasing the 
error rate This stage takes the irrelevant probes filtering into account, as probe 
201909_at, which is associated to the Y chromosome. 
The reuse phase begins when the probes have been filtered, and generates the 
meshes for the groups as well as the distribution of the individuals along the space. 
The mesh closest to the new case was then selected and the classification was made. 
To evaluate the proposed model, the system classified 90 individuals together with a 
new individual, and the results obtained were compared to the previous existing clas-
sifications. Table 1 shows the number of elements with an erroneous classification. In 
the revise phase, the CART algorithm is used to obtain both the significant and  
irrelevant probes and rules. Table 2 shows the final rules obtained. 
Table 1. Classification Errors 
 Type 1 Type 2 Type 3 
Total 46 12 33 
Predicted/Erroneous 47/5 9/0 35/4 
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219703_at≤0.25 && 207502_at≤0.5 && 1552619_a_at>0.25 
219703_at≤0.25 && 207502_at≤0.5 && 1552619_a_at≤0.25 && 242601_at>0.25 
&& 1553586_at≤0 
 
C2 219703_at≤0.25 && 207502_at>0.5 
C1 
219703_at≤0.25 && 207502_at≤0.5 && 1552619_a_at≤0.25 && 242601_at≤0.25 
 
219703_at≤0.25 && 207502_at≤0.5 && 1552619_a_at≤0.25 && 242601_at>0.25 
&& 1553586_at>0 
  
Fig. 1. Representation of low dimensionality probes with MDS 
To obtain a visual representation of the patient’s classification, we use the MDS 
[14] and the dimensionality of the data is reduced to three. Figures 1a and 1b repre-
sent the information once MDS has been applied and, as shown, the individuals of the 
different clusters are separated in the space.  
The system is able to incorporate the knowledge acquired in previous classifica-
tions and use it to perform new classifications, providing a much appreciated decision 
support tool. As demonstrated, the proposed system reduces the dimensionality based 
on the filtering of genes with little variability and those that do not allow a separation 
of individuals due to the distribution of data. It also presents a clustering technique 
based on the neuronal network ESOINN, which is validated with a PAM technique. 
Finally, the system incorporates a technique for knowledge extraction and presents it 
to the human experts in a very intuitive format.  
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